Chris Mayo, Consultant Primary Markets, London Stock Exchange (LSE)




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Chris Mayo, Consultant Primary Markets, London Stock Exchange (LSE)
Released on: January 12, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Chris Mayo discusses the advantages of listing on the London Stock Exchange, and the recent performance of various life science companies, comparing with the wider market.
  • Summary
  • Company
Chris Mayo discusses the advantages of listing on the London Stock Exchange, and the recent performance of various life science companies, comparing with the wider market.
London Stock Exchange